BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 27272219)

  • 1. How long may a breath sample be stored for at  -80 °C? A study of the stability of volatile organic compounds trapped onto a mixed Tenax:Carbograph trap adsorbent bed from exhaled breath.
    Kang S; Paul Thomas CL
    J Breath Res; 2016 Jun; 10(2):026011. PubMed ID: 27272219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Storage stability of exhaled breath on Tenax TA.
    Harshman SW; Mani N; Geier BA; Kwak J; Shepard P; Fan M; Sudberry GL; Mayes RS; Ott DK; Martin JA; Grigsby CC
    J Breath Res; 2016 Oct; 10(4):046008. PubMed ID: 27732570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of breath sample collection method and length of storage of breath samples in Tedlar bags on the level of selected volatiles assessed using gas chromatography-ion mobility spectrometry (GC-IMS).
    Czippelová B; Nováková S; Šarlinová M; Baranovičová E; Urbanová A; Turianiková Z; Krohová JČ; Halašová E; Škovierová H
    J Breath Res; 2024 May; 18(3):. PubMed ID: 38701772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD.
    Gaida A; Holz O; Nell C; Schuchardt S; Lavae-Mokhtari B; Kruse L; Boas U; Langejuergen J; Allers M; Zimmermann S; Vogelmeier C; Koczulla AR; Hohlfeld JM
    J Breath Res; 2016 Apr; 10(2):026006. PubMed ID: 27082437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of the adsorption performance of a multi-sorbent bed (Carbotrap, Carbopack X, Carboxen 569) and a Tenax TA adsorbent tube for the analysis of volatile organic compounds (VOCs).
    Gallego E; Roca FJ; Perales JF; Guardino X
    Talanta; 2010 May; 81(3):916-24. PubMed ID: 20298873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers.
    Peters AL; Gerritsen MG; Brinkman P; Zwinderman KAH; Vlaar APJ; Bos LD
    J Breath Res; 2017 Apr; 11(2):026003. PubMed ID: 28397711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of thermal desorption tubes on the variability of exhaled breath data.
    Jung AE; Davidson CN; Land CJ; Dash AI; Guess BT; Edmonds HS; Pitsch RL; Harshman SW
    J Breath Res; 2023 Dec; 18(1):. PubMed ID: 38096565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of volatile organic compounds in exhaled breath by gas chromatography-mass spectrometry combined with chemometric analysis.
    Dallinga JW; Smolinska A; van Schooten FJ
    Methods Mol Biol; 2014; 1198():251-63. PubMed ID: 25270934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An adaptive breath sampler for use with human subjects with an impaired respiratory function.
    Basanta M; Koimtzis T; Singh D; Wilson I; Thomas CL
    Analyst; 2007 Feb; 132(2):153-63. PubMed ID: 17260076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influences of mixed expiratory sampling parameters on exhaled volatile organic compound concentrations.
    Thekedar B; Oeh U; Szymczak W; Hoeschen C; Paretzke HG
    J Breath Res; 2011 Mar; 5(1):016001. PubMed ID: 21383425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the adsorbent material on volatile metabolites during in vitro and in vivo bio-sampling.
    Franchina FA; Zanella D; Dejong T; Focant JF
    Talanta; 2021 Jan; 222():121569. PubMed ID: 33167263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of a paced auditory serial addition test (PASAT) intervention on the profile of volatile organic compounds in human breath: a pilot study.
    Turner MA; Bandelow S; Edwards L; Patel P; Martin HJ; Wilson ID; Thomas CL
    J Breath Res; 2013 Mar; 7(1):017102. PubMed ID: 23445666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methodology validation, intra-subject reproducibility and stability of exhaled volatile organic compounds.
    Basanta M; Ibrahim B; Douce D; Morris M; Woodcock A; Fowler SJ
    J Breath Res; 2012 Jun; 6(2):026002. PubMed ID: 22549110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of breakthrough volumes of volatile chemical warfare agents on a poly(2,6-diphenylphenylene oxide)-based adsorbent and application to thermal desorption-gas chromatography/mass spectrometric analysis.
    Kanamori-Kataoka M; Seto Y
    J Chromatogr A; 2015 Sep; 1410():19-27. PubMed ID: 26239699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a standardized collection device for exhaled breath sampling onto thermal desorption tubes.
    Harshman SW; Pitsch RL; Davidson CN; Lee EM; Scott AM; Hill EM; Mainali P; Brooks ZE; Strayer KE; Schaeublin NM; Wiens TL; Brothers MC; Drummond LA; Yamamoto DP; Martin JA
    J Breath Res; 2020 May; 14(3):036004. PubMed ID: 32155613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors that influence the volatile organic compound content in human breath.
    Blanchet L; Smolinska A; Baranska A; Tigchelaar E; Swertz M; Zhernakova A; Dallinga JW; Wijmenga C; van Schooten FJ
    J Breath Res; 2017 Feb; 11(1):016013. PubMed ID: 28140379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the stability of a mixture of volatile organic compounds on sorbents for the determination of emissions from indoor materials and products using thermal desorption/gas chromatography/mass spectrometry.
    Brown VM; Crump DR; Plant NT; Pengelly I
    J Chromatogr A; 2014 Jul; 1350():1-9. PubMed ID: 24877978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.
    Sarbach C; Stevens P; Whiting J; Puget P; Humbert M; Cohen-Kaminsky S; Postaire E
    Ann Pharm Fr; 2013 Jul; 71(4):203-15. PubMed ID: 23835018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics pilot study to identify volatile organic compound markers of childhood asthma in exhaled breath.
    Gahleitner F; Guallar-Hoyas C; Beardsmore CS; Pandya HC; Thomas CP
    Bioanalysis; 2013 Sep; 5(18):2239-47. PubMed ID: 24053239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro volatile organic compound profiling using GC×GC-TOFMS to differentiate bacteria associated with lung infections: a proof-of-concept study.
    Nizio KD; Perrault KA; Troobnikoff AN; Ueland M; Shoma S; Iredell JR; Middleton PG; Forbes SL
    J Breath Res; 2016 Apr; 10(2):026008. PubMed ID: 27120170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.